New patent expiration for Takeda Pharms drug ROZEREM

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for ROZEREM
Annual Drug Patent Expirations for ROZEREM

Rozerem is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge.

ROZEREM drug price trends.

This drug has twelve patent family members in seven countries.

The generic ingredient in ROZEREM is ramelteon. One supplier is listed for this compound. Additional details are available on the ramelteon profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top